| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 4.13T | 4.10T | 3.87T | 3.54T | 2.80T |
| Gross Profit | 1.26T | 1.32T | 1.21T | 1.04T | 779.58B |
| EBITDA | 733.00B | 820.13B | 767.53B | 646.39B | 457.42B |
| Net Income | 376.39B | 439.61B | 393.43B | 326.40B | 224.93B |
Balance Sheet | |||||
| Total Assets | 6.42T | 5.77T | 5.64T | 4.88T | 4.35T |
| Cash, Cash Equivalents and Short-Term Investments | 439.70B | 385.57B | 403.18B | 289.98B | 316.67B |
| Total Debt | 1.42T | 1.22T | 1.27T | 1.12T | 1.01T |
| Total Liabilities | 2.72T | 2.43T | 2.44T | 2.20T | 1.99T |
| Stockholders Equity | 3.51T | 3.17T | 3.03T | 2.54T | 2.23T |
Cash Flow | |||||
| Free Cash Flow | 236.70B | 311.31B | 231.83B | 22.94B | 138.01B |
| Operating Cash Flow | 448.96B | 517.17B | 434.78B | 206.47B | 300.97B |
| Investing Cash Flow | -199.23B | -210.67B | -204.43B | -174.25B | -163.64B |
| Financing Cash Flow | -208.54B | -321.42B | -122.03B | -61.88B | -73.80B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥334.76B | 12.26 | ― | 2.99% | 5.65% | 11.14% | |
74 Outperform | ¥5.92T | 14.52 | ― | 4.06% | 0.69% | -12.55% | |
74 Outperform | ¥89.93B | 12.90 | ― | 4.79% | 0.52% | 20.09% | |
70 Outperform | ¥174.19B | 7.33 | 9.45% | 2.86% | 19.89% | 176.66% | |
65 Neutral | ¥2.91T | 13.56 | 7.55% | 2.22% | 0.09% | -17.07% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥1.16T | 15.32 | 9.16% | 3.98% | 2.49% | -10.13% |